1. Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
   Peter Kubatka et al, 2021, EPMA Journal CrossRef
2. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
   Sajad Fakhri et al, 2024, Cancer and Metastasis Reviews CrossRef
3. Effect of the flavonoid baicalin on the proliferative capacity of bovine mammary cells and their ability to regulate oxidative stress
   Marie-Hélène Perruchot et al, 2019, PeerJ CrossRef
4. Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism
   Yiqing Gu et al, 2022, International Journal of Molecular Sciences CrossRef
5. Exploring the anti-caries properties of baicalin against Streptococcus mutans: an in vitro study
   Arval Viji Elango et al, 2021, Biofouling CrossRef
6. Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach
   Laleh Arzi et al, 2022, Plants CrossRef
7. Chiral Flavonoids as Antitumor Agents
   Cláudia Pinto et al, 2021, Pharmaceuticals CrossRef
8. Latest research progress on anticancer effect of baicalin and its aglycone baicalein
   Lin Wang et al, 2022, Archives of Pharmacal Research CrossRef
9. Baicalin Inhibits Haemophilus Parasuis-Induced High-Mobility Group Box 1 Release during Inflammation
   Shulin Fu et al, 2018, International Journal of Molecular Sciences CrossRef
10. Molecular targets and therapeutic strategies for triple-negative breast cancer
    Yashasvi Bhat et al, 2023, Molecular Biology Reports CrossRef
11. Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis
    Ziqiang Yu et al, 2020, Molecular and Cellular Biochemistry CrossRef
12. Euphorbia factor L1 suppresses breast cancer liver metastasis via DDR1-mediated immune infiltration
    Dongjing Jiang et al, 2023, Aging CrossRef
13. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients
    Esmeralda García-Torralba et al, 2023, Frontiers in Oncology CrossRef
14. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1
    Zhihao Wen et al, 2024, The Journal of Gene Medicine CrossRef
15. Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo
    Anqi Zeng et al, 2020, Frontiers in Pharmacology CrossRef
16. Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
    Wen-Kai Yu et al, 2020, Frontiers in Pharmacology CrossRef
17. Exploring the Mechanism of Baicalin Intervention in Breast Cancer Based on MicroRNA Microarrays and Bioinformatics Strategies
    Anqi Ge et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
18. Study of the antitumor activity of the combination baicalin and epigallocatechin gallate in a murine model of vincristine-resistant breast cancer
    Dima Awajan et al, 2024, Pharmacia CrossRef
19. Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
    null Lee, 2019, Cancers CrossRef
20. Effectiveness of Chinese Herbal Medicine as a Complementary Treatment for Neutropenia Prevention and Immunity Modulation During Chemotherapy in Patients With Breast Cancer: Protocol for a Real-World Pragmatic Clinical Trial
    Kai-Hung Wang et al, 2024, JMIR Research Protocols CrossRef